HALEON PLC
LSE:HLN
Net Margin
HALEON PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| UK |
|
HALEON PLC
LSE:HLN
|
34.2B GBP |
13%
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
186.9B EUR |
15%
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
108.7B GBP |
9%
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
17%
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.1B USD |
-6%
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.6B EUR |
9%
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
7%
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
13%
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
853.5B INR |
14%
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
-19%
|
|
| IN |
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
646.2B INR |
24%
|
HALEON PLC
Glance View
In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe. HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on HALEON PLC's most recent financial statements, the company has Net Margin of 12.8%.
You don't have any saved screeners yet